Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Raymond B. Mailhot Vega, MD"'
Autor:
Julie A. Bradley, MD, MHCDS, Jayden Gracie, MD, Raymond B. Mailhot Vega, MD, MPH, Eric D. Brooks, MD, MHS, Tenna Burchianti, ARNP, Oluwadamilola T. Oladeru, MD, MA, MBA, Xiaoying Liang, PhD, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 10, Iss 2, Pp 94-104 (2023)
Purpose: Male breast cancer treatment involves multimodality therapy, including radiation therapy; nevertheless, few men have received proton therapy (PT) for it. Further, heart disease is an established leading cause of death in men, and radiation t
Externí odkaz:
https://doaj.org/article/dae50e17eb5f46cc9d655a4e0c7e82b5
Autor:
Jonathan S. Fakhry, M. Juliana Pena, Ariel Pomputius, Fantine Giap, MD, Raymond B. Mailhot Vega, MD
Publikováno v:
International Journal of Particle Therapy, Vol 10, Iss 1, Pp 51-58 (2023)
Purpose: Equitable inclusion of racial and ethnic participation in clinical trials is crucial to improving disparities in health care, especially for historically marginalized populations. Our study aims to describe the racial and ethnic demographics
Externí odkaz:
https://doaj.org/article/6ca57d42c8a74a6ea325b30a5c804061
Autor:
Eric D. Brooks, MD, Raymond B. Mailhot Vega, MD, MPH, Emma Vivers, MS, Teena Burchianti, ARNP, Xiaoying Liang, PhD, Lisa R. Spiguel, MD, Bharti Jasra, MBBS (MD), FACS, Nancy P. Mendenhall, MD, Oluwadamilola T. Oladeru, MD, MA, MBA, Julie A. Bradley, MD
Publikováno v:
International Journal of Particle Therapy, Vol 9, Iss 4, Pp 290-301 (2023)
Purpose: Treatment for bilateral breast cancer with radiation therapy is technically challenging. We evaluated the clinical and dosimetric outcomes of a small series of patients with synchronous bilateral breast cancer, including a photon dosimetric
Externí odkaz:
https://doaj.org/article/c1f1b02e1c4c49eab81f252b86405106
Autor:
Julie A. Bradley, MD, Xiaoying Liang, PhD, Raymond B. Mailhot Vega, MD, MPH, Chunbo Liu, PhD, Eric D. Brooks, MD, Teena Burchianti, ARNP, Emma Viviers, MS, Roi Dagan, MD, MS, Oluwadamilola T. Oladeru, MD, MA, MBA, Christopher G. Morris, MS, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 9, Iss 4, Pp 269-278 (2023)
Purpose: To determine the rib fracture rate in a cohort of patients with breast cancer treated with proton therapy. Patient and Methods: From a prospective database, we identified 225 patients treated with proton therapy between 2012 and 2020 (223 wo
Externí odkaz:
https://doaj.org/article/d3e5fc85fd7c428aadf2996f42a03e7b
Autor:
Wen Shen Looi, MBBS, FRCR, Julie A. Bradley, MD, Xiaoying Liang, PhD, Christiana M. Shaw, MD, Mark Leyngold, MD, Raymond B. Mailhot Vega, MD, MPH, Eric D. Brooks, MD, Michael S. Rutenberg, MD, PhD, Lisa R. Spiguel, MD, Fantine Giap, MD, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 4, Pp 55-67 (2022)
Purpose: Radiation-associated angiosarcoma (RAAS) is a rare complication among patients treated with radiation therapy for breast cancer. Hyperfractionated-accelerated reirradiation (HART) improves local control after surgery. Proton therapy may furt
Externí odkaz:
https://doaj.org/article/2ccaa648a49248e3b7243ea0fb688bf7
Autor:
Jonathan A. Baron, MD, Christopher M. Wright, MD, Russell Maxwell, MD, Michele M. Kim, PhD, Fantine Giap, MD, Raymond B. Mailhot Vega, MD, MPH, Bradford S. Hoppe, MD, MPH, Michael J. LaRiviere, MD, Amit Maity, MD, PhD, John P. Plastaras, MD, PhD, Ima Paydar, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101090- (2023)
Purpose: Combined modality therapy with multiagent chemotherapy and radiation therapy is a standard treatment option for aggressive mediastinal non-Hodgkin lymphomas (AMNHLs); however, concerns regarding acute and late radiation toxicities have fuele
Externí odkaz:
https://doaj.org/article/684c562a7fd7413887bbb92aacfaa521
Autor:
Ashley Way, MD, Savas Ozdemir, MD, Barbara Berges, RN, Nataliya Getman, MS, Xiaoying Liang, PhD, Nancy P. Mendenhall, MD, Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, David Cutter, MRCP, FRCR, DPhil, Raymond B. Mailhot Vega, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 4, Pp 76-81 (2021)
We present a case of recurrent pericardial effusion presenting during proton therapy in a 24-year-old female receiving mediastinal treatment for classical Hodgkin lymphoma. Pericardial effusion is typically considered an event accompanying lymphoma d
Externí odkaz:
https://doaj.org/article/d4df34c627c94d51a92719fb3b739ce5
Autor:
James E. Bates, MD, Stephanie Terezakis, MD, Christopher G. Morris, MS, Avani D. Rao, MD, Shuchi Sehgal, BA, Rahul Kumar, MBBS, Raymond B. Mailhot Vega, MD, MPH, Nancy P. Mendenhall, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 21-27 (2021)
Purpose: Early stage (stages I-II) classical Hodgkin lymphoma (cHL) is a highly curable disease typically diagnosed in adolescents and young adults (AYAs). Proton therapy can also reduce the late toxicity burden in this population, but data on its co
Externí odkaz:
https://doaj.org/article/4662bd6f283b47d2addc8493de90f859
Autor:
Raymond B. Mailhot Vega, MD, MPH, Sharon M. Castellino, MD, MSc, Qinglin Pei, PhD, Susan Parsons, MD, MRP, Kenneth B. Roberts, MD, David Hodgson, MD, MPH, Anne-Marie Charpentier, MD, Thomas J. Fitzgerald, MD, Sandy K. Kessel, Frank G. Keller, Kara Kelly, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 55-57 (2021)
Externí odkaz:
https://doaj.org/article/26833359dfdd4977a89be74a7e0e7ed4
Autor:
Malcolm D. Mattes, MD, Curtiland Deville, Jr, MD, Raymond B. Mailhot Vega, MD, Claire Y. Fung, MD, MS, Gita Suneja, MD, MS, John W. Shumway, Mudit Chowdhary, MD, Chirag Shah, MD, James E. Bates, MD, Pranshu Mohindra, MD, MBBS, Malika L. Siker, MD, Karen M. Winkfield, MD, PhD, Neha Vapiwala, MD, Trevor J. Royce, MD, MS, MPH
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100834- (2022)
ABSTRACT: Purpose: The radiation oncology workforce in the United States is comparatively less diverse than the U.S. population and U.S. medical school graduates. Workforce diversity correlates with higher quality care and outcomes. The purpose of th
Externí odkaz:
https://doaj.org/article/8e725c1b86a740af8336a7bfe6f806fb